在接受新辅助化疗或放射治疗的患有直肠癌的糖尿病患者中,甲福明对瘤回归度的影响

Nai-Yu Lin1, Kun-Yu Tsai2, Yen-Lin Huang3

  • 1Division of Colon and Rectal Surgery, Department of Surgery, Chang Gung Memorial Hospital at Linkou, No.5, Fuxing Street, Guishan District, Taoyuan, 333, Taiwan.

Scientific reports
|July 16, 2025
PubMed
概括

在接受新辅助化学放射治疗的局部晚期直肠癌患者中,使用甲胺可能会改善瘤反应,特别是增强瘤回归度 (TRG). 然而,整体存活率和无病存活率没有显著影响.